Bio Protocol vs IOTA — how do they compare? Bio Protocol trades at Rp439.86 (market cap Rp996,26M, Rp160,17M 24h volume), while IOTA trades at Rp589.59 (market cap Rp2,71T, Rp91,63M 24h volume). The key difference: IOTA is far larger — about 2720.2× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while IOTA's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and IOTA for 49 Days on average.
| BIO | MIOTA | |
|---|---|---|
Market Cap | Rp996,26M | Rp2,71T |
Volume (24h) | Rp160,17M | Rp91,63M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 4,6B MIOTA |
Typical Hold Time | 18 Days | 49 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
IOTA is trading at Rp599.3 with a market cap of Rp2.75T, showing bearish technical signals overall with moving averages indicating selling pressure while oscillators remain neutral. The price is currently testing support at Rp596 with resistance at Rp617. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious with technical weakness dominating. Key opportunities include potential bounce from support levels, while risks include continued bearish momentum and lack of recent fundamental catalysts. Investors should monitor volume patterns and network activity for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →IOTA is a distributed ledger with one big difference: it isn’t actually a blockchain. Instead, its proprietary technology is known as Tangle, a system of nodes that confirm transactions. The foundation behind this platform says this offers far greater speeds than conventional blockchains — and an ideal footprint for the ever-expanding Internet of Things ecosystem.
Read more on MIOTA →